Front Range Pharmaceuticals
CompanyUnited States
Front Range Pharmaceuticals develops one asset, in phase 2 (FRP-003 in long COVID). Mostly small molecule; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 2
- 0
- Trials
- 0
- Signals
Pipeline
1Phase 2, Small molecule, long COVID
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies4